Sökning: WFRF:(Raine Amanda) > Deep targeted seque...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 04007naa a22006973a 4500 | |
001 | 19956163 | |
003 | SE-LIBR | |
005 | 20161216154257.0 | |
007 | cr|||||||||||| | |
008 | 161216s2016 sw |||| o |||| ||eng c | |
024 | 7 | a http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-1284762 uri |
024 | 7 | a urn:nbn:se:umu:diva-1284762 urn |
024 | 7 | a 10.18632/oncotarget.117732 doi |
040 | a S | |
041 | 0 | a eng |
042 | 9 EPLK | |
100 | 1 | a Lindqvist, C. Marten4 aut |
245 | 1 0 | a Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genesh [Elektronisk resurs] |
260 | c 2016 | |
500 | a Published | |
506 | 0 | a gratis |
520 | a To characterize the mutational patterns of acute lymphoblastic leukemia (ALL) we performed deep next generation sequencing of 872 cancer genes in 172 diagnostic and 24 relapse samples from 172 pediatric ALL patients. We found an overall greater mutational burden and more driver mutations in T-cell ALL (T-ALL) patients compared to B-cell precursor ALL (BCP-ALL) patients. In addition, the majority of the mutations in T-ALL had occurred in the original leukemic clone, while most of the mutations in BCP-ALL were subclonal. BCP-ALL patients carrying any of the recurrent translocations ETV6-RUNX1, BCR-ABL or TCF3-PBX1 harbored few mutations in driver genes compared to other BCP-ALL patients. Specifically in BCP-ALL, we identified ATRX as a novel putative driver gene and uncovered an association between somatic mutations in the Notch signaling pathway at ALL diagnosis and increased risk of relapse. Furthermore, we identified EP300, ARID1A and SH2B3 as relapse-associated genes. The genes highlighted in our study were frequently involved in epigenetic regulation, associated with germline susceptibility to ALL, and present in minor subclones at diagnosis that became dominant at relapse. We observed a high degree of clonal heterogeneity and evolution between diagnosis and relapse in both BCP-ALL and T-ALL, which could have implications for the treatment efficiency. | |
650 | 7 | a Medical and Health Sciences2 hsv |
650 | 7 | a Clinical Medicine2 hsv |
650 | 7 | a Cancer and Oncology2 hsv |
650 | 7 | a Medicin och hälsovetenskap2 hsv |
650 | 7 | a Klinisk medicin2 hsv |
650 | 7 | a Cancer och onkologi2 hsv |
653 | 0 | a acute lymphoblastic leukemia |
653 | 0 | a targeted next generation sequencing |
653 | 0 | a somatic mutation |
653 | 0 | a relapse |
653 | 0 | a clonal evolution |
700 | 1 | a Lundmark, Anders4 aut |
700 | 1 | a Nordlund, Jessica4 aut |
700 | 1 | a Freyhult, Eva4 aut |
700 | 1 | a Ekman, Diana4 aut |
700 | 1 | a Almlof, Jonas Carlsson4 aut |
700 | 1 | a Raine, Amanda4 aut |
700 | 1 | a Overnas, Elin4 aut |
700 | 1 | a Abrahamsson, Jonas4 aut |
700 | 1 | a Frost, Britt-Marie4 aut |
700 | 1 | a Grander, Dan4 aut |
700 | 1 | a Heyman, Mats4 aut |
700 | 1 | a Palle, Josefine4 aut |
700 | 1 | a Forestier, Erik4 aut |
700 | 1 | a Lonnerholm, Gudmar4 aut |
700 | 1 | a Berglund, Eva C.4 aut |
700 | 1 | a Syvanen, Ann-Christine4 aut |
710 | 1 2 | a Umeå universitetb Medicinska fakulteten4 pbl0 268483 |
772 | 1 8 | i channel recordw 18813935 |
773 | 0 8 | i Värdpublikationt OncoTargetg 7:39, 64071-64088x 1949-2553 |
856 | 4 0 | u http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-128476 |
856 | 4 0 | u http://dx.doi.org/10.18632/oncotarget.11773 |
856 | 4 0 | u http://umu.diva-portal.org/smash/get/diva2:1056619/FULLTEXT01 |
910 | 2 s | 6 710a Umeå universitet.b Medicinsk-odontologiska fakultetenu Umeå universitet.b Medicinska fakulteten |
910 | 2 s | 6 710a Medicinska fakulteten vid Umeå universitetu Umeå universitet.b Medicinska fakulteten |
841 | 5 APISa x ab 161216||0000|||||001||||||000000e 1 | |
024 | 7 | 5 APISa urn:nbn:se:umu:diva-1284762 urn |
852 | 5 APISb APIS | |
856 | 4 0 | 5 APISu http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-128476 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy